Your browser doesn't support javascript.
loading
Activatable Heavy-Atom-Free Photosensitizer with Large Stokes Shift and a NIR-II Emission Harnessing Rhodamine Ring-Opening Strategy.
Liu, Chuangjun; Ding, Qihang; Xu, Yinling; Bai, Qian; Jiang, Yingchun; Shi, Yihang; Ma, Mengru; Sun, Yuanyuan; Lu, Qiang; Chen, Xinyu; Liu, Junhang; Yi, Gaoyu; Yang, Yang; Wang, Tiezhen; Zhang, Shuai; Wang, Pengfei; Kim, Jong Seung.
Afiliação
  • Liu C; College of Chemistry and Pharmaceutical Engineering, Huanghuai University, Zhumadian 463000, China.
  • Ding Q; Henan Key Laboratory of Digital Medicine, Affiliated Zhumadian Central Hospital of Huanghuai University, Zhumadian 463000, China.
  • Xu Y; Department of Chemistry, Korea University, Seoul 02841, Korea.
  • Bai Q; Digital Medicine Center, Pingyu People's Hospital, Zhumadian 463400, China.
  • Jiang Y; Department of Medical Oncology, Harbin Medical University Cancer Hospital, 150 Haping Road Nangang District, Harbin, Heilongjiang Province 150040, China.
  • Shi Y; College of Medicine, Huanghuai University, Zhumadian 463000, China.
  • Ma M; College of Chemistry and Pharmaceutical Engineering, Huanghuai University, Zhumadian 463000, China.
  • Sun Y; College of Chemistry and Pharmaceutical Engineering, Huanghuai University, Zhumadian 463000, China.
  • Lu Q; College of Chemistry and Pharmaceutical Engineering, Huanghuai University, Zhumadian 463000, China.
  • Chen X; College of Chemistry and Pharmaceutical Engineering, Huanghuai University, Zhumadian 463000, China.
  • Liu J; College of Chemistry and Pharmaceutical Engineering, Huanghuai University, Zhumadian 463000, China.
  • Yi G; College of Chemistry and Pharmaceutical Engineering, Huanghuai University, Zhumadian 463000, China.
  • Yang Y; College of Chemistry and Pharmaceutical Engineering, Huanghuai University, Zhumadian 463000, China.
  • Wang T; Henan Key Laboratory of Digital Medicine, Affiliated Zhumadian Central Hospital of Huanghuai University, Zhumadian 463000, China.
  • Zhang S; Digital Medicine Center, Pingyu People's Hospital, Zhumadian 463400, China.
  • Wang P; Department of Medical Oncology, Harbin Medical University Cancer Hospital, 150 Haping Road Nangang District, Harbin, Heilongjiang Province 150040, China.
  • Kim JS; Digital Medicine Center, Pingyu People's Hospital, Zhumadian 463400, China.
Anal Chem ; 96(35): 14230-14238, 2024 Sep 03.
Article em En | MEDLINE | ID: mdl-39172624
ABSTRACT
Activatable photosensitizers (PSs) generating 1O2 only under specific conditions can minimize concomitant injury to normal tissues. Heavy-atom-free PSs hold the merits of low dark toxicity, long triplet-state lifetimes, good photostability, and relatively low cost. PSs with emission in the second near-infrared (NIR-II) window are highly valuable for deep-tissue, high-contrast imaging. Herein, we have designed and synthesized a series of heavy-atom-free PSs by a one-step reaction between an easily accessible rhodamine derivative and commercially available thiophene aldehydes. One of the as-prepared PSs, 2b-3T, exhibits emission maxima at 810 nm and tails to the NIR-II region at 1140 nm, together with large Stokes shift (178 nm). Importantly, the newly developed PSs, featuring functional carboxylic acid groups, present promising opportunities as versatile platforms for creating activatable PSs. To validate our concept, we developed Cu2+/pH-activatable PSs using the spirocyclization mechanism of rhodamine. Ultimately, we showcased the effectiveness of these innovative PSs in photodynamic therapy through in vitro experiments.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Rodaminas / Fármacos Fotossensibilizantes / Raios Infravermelhos Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Rodaminas / Fármacos Fotossensibilizantes / Raios Infravermelhos Idioma: En Ano de publicação: 2024 Tipo de documento: Article